Clinical Trials

dystrophin
Blog Post

Simply Stated: What is Duchenne Muscular Dystrophy?

By Sujatha Gurunathan | February 16, 2022
Featured Article

A New Direction for Charcot-Marie-Tooth Disease

By MDA Staff | February 16, 2022
Blog Post

Simply Stated: What is Becker Muscular Dystrophy?

By Sujatha Gurunathan | January 6, 2022
Blog Post

FDA Approves argenx’s Vyvgart for Treatment of gMG

By Sujatha Gurunathan | December 20, 2021
Blog Post

Clinical Trial Alert: Early Phase Study of SRP-9001 in Boys with DMD

By Sujatha Gurunathan | November 9, 2021
Blog Post

Clinical Trial Alert: Phase 2/3 Study of Tideglusib (AMO-02) in Children and Adolescents with Congenital Myotonic Dystrophy

By Sujatha Gurunathan | November 9, 2021
Blog Post

Clinical Trial Alert: Phase 3b Study of Oral Edaravone in Adults with ALS

By Sujatha Gurunathan | October 11, 2021
Blog Post

Research Study Alert: Observational Study of Clinical and Electrophysiological Outcomes in Adults with CMT

By Sujatha Gurunathan | October 11, 2021
Blog Post

Capricor Announces Positive Results from its Phase 2 Study of CAP-1002 to Treat DMD

By Sujatha Gurunathan | September 30, 2021
Blog Post

Clinical Trial Alert: Phase 2 Study of Ataluren in Children with Nonsense Mutation DMD

By MDA Staff | September 20, 2021